Trial Profile
A feasibility test on a postoperative docetaxel plus TS-1 [S 1] therapy for the patients with stage IIIA or stage IIIB gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 26 Jun 2012 Actual end date (Dec 2012) added as reported by University Hospital Medical Information Network - Japan.
- 26 Jun 2012 Trial phase changed from I to II as reported by University Hospital Medical Information Network - Japan.
- 26 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.